InsidersTradesSigma
Track the ノイルイミューン・バイオテック株式会社 share price and the full management transaction log of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, ノイルイミューン・バイオテック株式会社 has recorded 11 public disclosures. Market capitalisation: €8,802.9bn. The latest transaction was reported on 31 July 2024 (Holding update). Among the most active insiders: TSURUKAME CO.,LTD. All data is accessible without an account.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ノイルイミューン・バイオテック株式会社 Buy (bullish), based on 16 analysts. Average price target: JP¥6,375.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,356 of 29,063 companies
38.3
score / 100
Value42
Quality35
FCF yld7.1%
Earn yld-1.7%
EV/EBITDA18.8x
ROE-2.3%
Gross mgn65%
Net mgn-3.4%
Debt/EBITDA6.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 July 2024
Declarations11 total
34.8% of flowShareXTKSEDINET:S100U46F
33.9% of flowShareXTKSEDINET:S100U39W
ShareXTKSEDINET:S100TMVG
48.2% of flowShareXTKSEDINET:S100THRM
ShareXTKSEDINET:S100SZW9
15.4% of flowShareXTKSEDINET:S100SV0E
0.0001% mcap100.0% of flowShareXTKSEDINET:S100RC2H
0.0000% mcap100.0% of flowShareXTKSEDINET:S100RC1V
0.0000% mcap100.0% of flowShareXTKSEDINET:S100RC1P
0.0000% mcap100.0% of flowShareXTKSEDINET:S100R0PC
0.0000% mcap100.0% of flowShareXTKSEDINET:S100R6G9
11 of 11 declarations
About ノイルイミューン・バイオテック株式会社
Noil Immune Biotech Co., Ltd. is a company focused on the health and pharmaceutical sector, specializing in the development of biopharmaceutical solutions. It is listed on the XTKS market.